JN Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 63: 1373-1384, 1990;
0022-3077/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benveniste, M.
Right arrow Articles by Mayer, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benveniste, M.
Right arrow Articles by Mayer, M. L.

Journal of Neurophysiology, Vol 63, Issue 6 1373-1384, Copyright © 1990 by APS


ARTICLES

Concentration-jump experiments with NMDA antagonists in mouse cultured hippocampal neurons

M. Benveniste, J. M. Mienville, E. Sernagor and M. L. Mayer
Unit of Neurophysiology and Biophysics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

1. Voltage-clamp experiments were used to study N-methyl-D-aspartic acid (NMDA) receptor antagonists applied by fast perfusion to mouse hippocampal neurons in dissociated culture. 2. Preincubation with the NMDA antagonists zinc (3-30 microM) and magnesium (30-300 microM) reduced subsequent responses to 100 microM NMDA applied together with these antagonists. No time dependence of antagonism was observed when responses were measured at the start and at the end of NMDA pulses 1.25-1.5 s in duration. 3. Two competitive antagonists of similar affinity in equilibrium experiments, D-2-amino-5-phosphonopentanoic acid (D-AP5) and 3-((+-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP), had different profiles of action when applied as described above. With D-AP5, pulses of NMDA produced fast-on, fast-off responses, of reduced amplitude, similar to the effect of Zn and Mg. Responses to NMDA in the presence of CPP were also of reduced amplitude but, in addition, showed slow activation, such that the antagonist action of CPP decreased with time after the application of NMDA. 4. In the presence of 3 microM glycine and NMDA receptor antagonists with activity at the glycine modulatory site, either kynurenic acid (Kyn), 7-chlorokynurenic acid (7Cl-Kyn), or 5-chloro-indole-2-carboxylic acid (5Cl-I2CA), NMDA-evoked responses showed apparent use-dependent antagonism, such that the peak response to NMDA was much greater than the equilibrium response. A similar effect was produced by preincubation with low concentrations of glycine (less than 300 nM), which enhances desensitization of responses to NMDA. The apparent use-dependent action of glycine antagonists could be reversed on raising the glycine concentration and did not vary appreciably with changes in membrane potential over the range -60 to +50 mV. 5. Concentration-jump application of NMDA antagonists, in the presence of 100 microM NMDA and 3 microM glycine, were used to study antagonist association and dissociation kinetics directly. For D-AP5 and CPP, the dissociation rate was independent of antagonist concentration, and approximately 15 times faster for D-AP5 (19.6 s-1) than for CPP (1.36 s-1). The association rate for D-AP5 and CPP increased with antagonist concentration in a linear manner over the range 3-30 microM and was slower for CPP than for D-AP5, consistent with their similar potency at equilibrium. 6. In contrast to results obtained with CPP and D-AP5, the association rate for 7Cl-Kyn was approximately 3 times slower than the dissociation rate and did not change with concentration of antagonist.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
P. A. Frizelle, P. E. Chen, and D. J. A. Wyllie
Equilibrium Constants for (R)-[(S)-1-(4-Bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic Acid (NVP-AAM077) Acting at Recombinant NR1/NR2A and NR1/NR2B N-Methyl-D-aspartate Receptors: Implications for Studies of Synaptic Transmission
Mol. Pharmacol., September 1, 2006; 70(3): 1022 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Zhao, J. P. Adams, and S. M. Dudek
Pattern-Dependent Role of NMDA Receptors in Action Potential Generation: Consequences on Extracellular Signal-Regulated Kinase Activation
J. Neurosci., July 27, 2005; 25(30): 7032 - 7039.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Martina, Y. Gorfinkel, S. Halman, J. A. Lowe, P. Periyalwar, C. J. Schmidt, and R. Bergeron
Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels
J. Physiol., June 1, 2004; 557(2): 489 - 500.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Nahum-Levy, E. Tam, S. Shavit, and M. Benveniste
Glutamate But Not Glycine Agonist Affinity for NMDA Receptors Is Influenced by Small Cations
J. Neurosci., April 1, 2002; 22(7): 2550 - 2560.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. C. Burgard, W. Niforatos, T. van Biesen, K. J. Lynch, K. L. Kage, E. Touma, E. A. Kowaluk, and M. F. Jarvis
Competitive Antagonism of Recombinant P2X2/3 Receptors by 2',3'-O-(2,4,6-Trinitrophenyl) Adenosine 5'-Triphosphate (TNP-ATP)
Mol. Pharmacol., April 13, 2001; 58(6): 1502 - 1510.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. I. Sobolevsky, M. V. Yelshansky, and B. I. Khodorov
Eosine-Induced Blockade of N-Methyl-D-aspartate Channels in Acutely Isolated Rat Hippocampal Neurons
Mol. Pharmacol., February 1, 2000; 57(2): 334 - 341.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
A. I. Sobolevsky, S. G. Koshelev, and B. I. Khodorov
Probing of NMDA Channels with Fast Blockers
J. Neurosci., December 15, 1999; 19(24): 10611 - 10626.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
W. Danysz and C. G. Parsons
Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications
Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. V. Jones, Y. Sahara, J. A. Dzubay, and G. L. Westbrook
Defining Affinity with the GABAA Receptor
J. Neurosci., November 1, 1998; 18(21): 8590 - 8604.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. N. C. Kew, J. G. Richards, V. Mutel, and J. A. Kemp
Developmental Changes in NMDA Receptor Glycine Affinity and Ifenprodil Sensitivity Reveal Three Distinct Populations of NMDA Receptors in Individual Rat Cortical Neurons
J. Neurosci., March 15, 1998; 18(6): 1935 - 1943.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Matsubayashi, M. Alkondon, E. F. R. Pereira, K. L. Swanson, and E. X. Albuquerque
Strychnine: A Potent Competitive Antagonist of alpha -Bungarotoxin-Sensitive Nicotinic Acetylcholine Receptors In Rat Hippocampal Neurons
J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 904 - 913.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online